BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ical.marudot.com//iCal Event Maker
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/London
LAST-MODIFIED:20250410T142247Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260415T100842Z
UID:1776241402482-82009@ical.marudot.com
DTSTART;TZID=Europe/London:20260609T112000
DTEND;TZID=Europe/London:20260609T114000
SUMMARY:Lung Screening to Radiogenomics: Future Directions in CT-Based Precision Diagnostics for Non-Small Cell Lung Cancer (NSCLC)
URL:https://academy.eu.medical.canon/courses/lung-screening-to-radiogenomics-future-directions-in-ct-based-precision-diagnostics-for-non-small-cell-lung-cancer-nsclc-2/
DESCRIPTION:This future-focused session will introduce a flexible and comprehensive lung screening solution and explore how emerging radiogenomics approaches may extend the role of CT in diagnostics beyond detection towards non-invasive characterisation of tumour biology in non-small cell lung cancer (NSCLC). Drawing on collaborative research with NHS Greater Glasgow & Clyde and the University of Glasgow\, the presentation will outline ongoing work to investigate whether routine CT imaging can help predict tumour mutation status and support more rapid diagnostic assessment. \n\nThe session will describe the technological direction of this work\, its potential clinical relevance\, and the possible value it may offer to patients\, clinicians\, and healthcare providers. It will also consider how advances in CT-based image analysis may contribute to future precision diagnostic pathways\, including improved stratification and more informed treatment planning. \n\nDescribe the key components of a flexible and comprehensive lung screening solution\nSummarise the aims and direction of the radiogenomics research being undertaken with NHS Greater Glasgow & Clyde and the University of Glasgow\nRecognise the potential role of CT imaging in supporting non-invasive assessment of NSCLC tumour mutation status \nExplain how emerging radiogenomics technologies may contribute to future patient stratification and diagnostic pathways in lung cancer \n\nThis session has been CPD accredited by The College of Radiographers.\n\nThis session will be hosted by Canon Medical Systems UK during UKIO 2026.
LOCATION:UKIO 2026\, Stand A29
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Lung Screening to Radiogenomics: Future Directions in CT-Based Precision Diagnostics for Non-Small Cell Lung Cancer (NSCLC)
TRIGGER:-PT1H
END:VALARM
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Lung Screening to Radiogenomics: Future Directions in CT-Based Precision Diagnostics for Non-Small Cell Lung Cancer (NSCLC)
TRIGGER:-PT30M
END:VALARM
END:VEVENT
END:VCALENDAR